Neuland Laboratories share price drops 5% as Q4 EBITDA falls 52.3% YoY to Rs 51 crore Stock Market · May 16, 2025
Neuland Laboratories receives one FDA observation following inspection of Unit 2 facility in Telangana Corporates · May 2, 2025
Neuland Laboratories shares surge nearly 10% amid AbbVie’s phase 2 setback on schizophrenia drug Stock Market · Nov 12, 2024
Neuland Laboratories Q2 FY25 Results: Revenue down 25.1% YoY to ₹315.2 crore, PAT declines 64.1% Corporates · Nov 6, 2024
